Skip to main content
Equibles

CITADEL ADVISORS LLC

Position in BTAIQ — BioXcel Therapeutics, Inc.

CIK 1423053 MIAMI, FL
Back to BTAIQ Full portfolio

Position in BTAIQ

as of Jun 30, 2026 · filed Sep 2, 2026
Position Value
$210,400
+$189,806 QoQ
Shares Held
149,220
+1211.5% QoQ
Ownership
0.477%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#8
of 47 holders
Holding Since
Mar 2020
22 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in BTAIQ Over Time

Shares Held

Position Value (USD)

Derivatives in BTAIQ

reported options exposure · as of Dec 31, 2024
CallValue
$0
CallShares
2,156
PutValue
$0
PutShares
3,712

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Jun 30, 2026

CITADEL ADVISORS LLC holds $1,255,675,824 across 65 Drug Manufacturers - Specialty & Generic names. BTAIQ ranks #47 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 ELAN
Elanco Animal Health Inc
 9,668,611 $237,944,516
2 ZTS
Zoetis Inc.
 3,188,263 $229,108,578
3 UTHR
UNITED THERAPEUTICS Corp
 304,692 $165,091,266
4 LNTH
Lantheus Holdings, Inc.
 1,376,480 $152,706,691
5 INDV
Indivior Pharmaceuticals, Inc.
 2,667,827 $109,460,941
6 ALKS
Alkermes plc.
 1,645,101 $86,203,291
7 SUPN
Supernus Pharmaceuticals, Inc.
 1,373,982 $63,903,902
8 HIMS
Hims & Hers Health, Inc.
 846,936 $29,363,271

All Filings in BTAIQ

Export CSV
50 filing rows on record
Report Date Value (USD) Shares
2025-06-30 $20,594 11,378
2024-12-31 — 34,500
2024-12-31 — 59,400
2024-09-30 — 27,700
2024-09-30 — 22,200
2024-06-30 — 65,800
2024-06-30 — 20,500
2024-03-31 — 40,643
2024-03-31 — 11,900
2024-03-31 — 77,700
2023-12-31 — 88,900
2023-12-31 — 57,500
2023-12-31 — 5,330
2023-09-30 — 14,300
2023-09-30 — 107,000
2023-09-30 — 33,400
2023-06-30 — 86,500
2023-06-30 — 98,800
2023-06-30 — 14,529
2023-03-31 — 41,300
2023-03-31 — 84,432
2023-03-31 — 14,100
2022-12-31 — 93,700
2022-12-31 — 46,611
2022-12-31 — 23,000
2022-09-30 — 20,000
2022-09-30 — 57,094
2022-09-30 — 107,600
2022-06-30 — 43,957
2022-06-30 — 42,100
2022-06-30 — 99,600
2022-03-31 — 81,300
2022-03-31 — 36,500
2022-03-31 — 47,713
2021-12-31 — 107,500
2021-12-31 — 64,800
2021-12-31 — 47,829
2021-09-30 — 33,110
2021-09-30 — 62,700
2021-09-30 — 72,500
2021-06-30 — 81,400
2021-06-30 — 43,700
2021-06-30 — 79,671
2021-03-31 — 70,789
2021-03-31 — 41,300
2021-03-31 — 60,300
2020-12-31 — 72,700
2020-12-31 — 48,400
2020-12-31 — 814,242
2020-09-30 — 749,621